Sai Life Sciences sets up Peptide Research Center in India

04 Apr 2025 Evaluate

Sai Life Sciences has set up a dedicated Peptide Research Center at its integrated R&D Campus in Hyderabad, India. The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates. The facility integrates automation, advanced liquid handling, robotics, and high-throughput systems, enhancing precision, scalability, and efficiency in the development of novel peptide-based therapeutics.

The new Peptide Research Center will be integrated with company’s end-to-end discovery services, spanning synthetic and medicinal chemistry, biology, DMPK, and toxicology. This holistic approach ensures seamless transitions across different stages of drug discovery, accelerating timelines and enhancing success rates for peptide-based drug development.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.

Sai Life Sciences Share Price

679.50 -9.50 (-1.38%)
28-Apr-2025 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1836.55
Dr. Reddys Lab 1200.00
Cipla 1553.00
Lupin 2106.10
Zydus Lifesciences 881.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...